Secondary Logo

Journal Logo

Parkinson disease

Enhance nursing knowledge

doi: 10.1097/01.NURSE.0000611468.89123.5d
CE Connection

For more than 116 additional continuing-education articles related to neurological topics, go to

Earn CE credit online: Go to and receive a certificate within minutes.

Nursing2019 will no longer facilitate mail-in continuing-education tests. All CE tests must be taken online at Please address any questions to customer service at 1-800-787-8985.

Back to Top | Article Outline

INSTRUCTIONS Parkinson disease: Enhance nursing knowledge


  • Read the article. The test for this CE activity is to be taken online at
  • You'll need to create (it's free!) and log in to your personal CE Planner account before taking online tests. Your planner will keep track of all your Lippincott Professional Development online CE activities for you.
  • There's only one correct answer for each question. A passing score for this test is 13 correct answers. If you pass, you can print your certificate of earned contact hours and access the answer key. If you fail, you have the option of taking the test again at no additional cost.
  • For questions, contact Lippincott Professional Development: 1-800-787-8985.
  • Registration deadline is September 3, 2021.
Back to Top | Article Outline


Lippincott Professional Development will award 1.0 contact hour and 0.5 pharmacology credit for this continuing nursing education activity. Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.0 contact hour, and the District of Columbia, Georgia, and Florida CE Broker #50-1223.

Payment: The registration fee for this test is $12.95.

Parkinson disease: Enhance nursing knowledge

GENERAL PURPOSE: To provide information on the care of patients with PD. LEARNING OBJECTIVES/OUTCOMES: After completing this continuing-education activity, you should be able to: 1. Describe the pathophysiology of PD. 2. List management strategies for patients with PD. 3. Identify nursing considerations for patients with PD.

  1. PD is caused by
    1. a bacterial infection.
    2. a traumatic brain injury.
    3. dopamine deficiency.
  2. A key neuropathology in PD is
    1. amyloid angiopathy.
    2. Lewy body deposition.
    3. neurofibrillary degeneration.
  3. Dopamine is a neurotransmitter produced in the
    1. subthalamic nucleus.
    2. thalamus.
    3. substantia nigra.
  4. Motor signs of PD include
    1. muscle atonia.
    2. postural instability.
    3. macrographia.
  5. What percentage of dopamine-producing neurons have failed when bradykinesia occurs in patients with PD?
    1. 30% to 40%
    2. 50% to 60%
    3. 70% to 80%
  6. The fast-moving, forward leaning movement in patients with PD is best described as
    1. festination.
    2. high-stepping gait.
    3. waddling gait.
  7. A common clinical finding in patients with PD is
    1. anasarca.
    2. unintended weight loss.
    3. hyperosmia.
  8. Patients with autonomic nervous system dysfunction may present with
    1. diarrhea.
    2. urinary incontinence.
    3. hypertension.
  9. In Stage 3 of PD, a patient's signs and symptoms
    1. are generally mild.
    2. may include hallucinations and delusions.
    3. significantly impair activities of daily living.
  10. Which imaging study is used to confirm abnormalities in dopamine transmission in the basal ganglia?
    1. DaT
    2. PET
    3. MRI
  11. Which statement about levodopa is correct?
    1. It is the immediate metabolic precursor of dopamine.
    2. It is converted to acetylcholine in the liver.
    3. Less than 50% of patients with idiopathic PD respond to treatment with levodopa.
  12. Carbidopa and levodopa enteral suspension is
    1. rapidly metabolized by the first-pass effect.
    2. administered orally.
    3. contraindicated in patients taking nonselective MAOIs.
  13. A hypertensive crisis could occur in patients taking rasagiline when combined with foods that contain
    1. gliadin.
    2. tyramine.
    3. glutenin.
  14. Which statement about COMT inhibitors is correct?
    1. They must be taken without food.
    2. They commonly cause renal dysfunction.
    3. They may cause dark-colored urine.
  15. Amantadine is a(n)
    1. anticholinergic drug.
    2. antiviral drug.
    3. dopamine agonist.
  16. Given the complex pharmacotherapies associated with PD, healthcare professionals must be aware that
    1. once a dosage is found to be effective, it is best not to make dosage adjustments.
    2. dyskinesias may develop after long-term use or high dosages of medication.
    3. medications can be safely withdrawn abruptly when necessary.
  17. Possible surgical complications associated with DBS include
    1. seizures.
    2. dysarthria.
    3. facial contractions.
  18. Explain to patients with PD that maintaining motor strength, flexibility, and function may be accomplished with
    1. exercise and physiotherapy.
    2. dietary adjustments.
    3. frequent rest and periods of inactivity.
Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.